259.90 -0.35 (-0.13%)
After hours: 7:53PM EDT
|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's range||259.31 - 262.44|
|52-week range||191.36 - 272.07|
|Beta (3Y Monthly)||0.75|
|PE ratio (TTM)||21.66|
|Earnings date||16 Oct 2018|
|Forward dividend & yield||3.60 (1.39%)|
|1y target est||293.62|
Analysts are upbeat on the health insurer’s earnings. Investors might be looking for more than a beat.
Dow Jones futures: In a stock market correction, it's a good time to build a watch list. Check out Apple, UnitedHealth, Microsoft and other top stocks with strong relative strength.
In the latest trading session, UnitedHealth Group (UNH) closed at $259.41, marking a +0.89% move from the previous day.
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
UnitedHealth Group (UNH) has a market capitalization of $260 billion and is the largest managed healthcare company in the United States. It operates through two subsidiaries: UnitedHealthcare and Optum. UnitedHealthcare offers health benefits, and Optum offers health services across complementary platforms.
When UnitedHealth Group (UNH) releases its third quarter of fiscal 2018 earnings results on October 16, analysts expect it to register adjusted EPS of ~$3.29, a ~23.8% growth YoY (year-over-year). In the second quarter, it reported adjusted EPS of ~$3.14, representing a ~27.6% YoY growth.
On October 16, UnitedHealth Group (UNH) is expected to announce its third quarter of fiscal 2018 earnings. Its sales are expected to grow 12% YoY (year-over-year) to $56.3 billion. In the second quarter of fiscal 2018, it had sales of $56.1 billion, representing ~12.1% YoY growth, which was in line with analysts’ estimates.
UnitedHealth Group (UNH) is the leading health insurance company in the United States. This managed healthcare company is focused on establishing itself as a diversified healthcare business and has been recently undertaking a number of strategic acquisitions aimed at that goal.
Stock futures fell as Treasury yields hit fresh 7-year highs. Apple, Boeing and UnitedHealth are highly rated Dow stocks that have held up well as growth stocks sell off in a red October.
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IBD Stock Of The Day: Centene has a new buy point after rallying from an April breakout. Managed care stocks have been winners in 2018, and are holding up well now.
When UnitedHealth Group Incorporated (NYSE:UNH) announced its most recent earnings (30 June 2018), I did two things: looked at its past earnings track record, then look at what is happening Read More...
UnitedHealth Group is a leading managed healthcare firm in the United States. It offers healthcare products and insurance services through its two divisions: UnitedHealthcare and Optum. The company recently acquired Genoa Healthcare to expand its OptumRx business.
UNH Stock Hits 52-Week High: Can It Sustain the Momentum? On September 28, UnitedHealth Group (UNH) announced the acquisition of pharmacy company Genoa Healthcare for nearly $2.5 billion from Advent International. The Genoa Healthcare business will be added to the company’s pharmacy benefits business division, OptumRx.
UnitedHealth Group (UNH) is one of the largest Fortune 500 companies. It is the leading managed healthcare company in the United States. It operates across two business segments: UnitedHealthcare and Optum. In this part of the series, let’s look at analysts’ recommendations for UNH stock.
For years, Spyros Panos seemed like a successful orthopedic surgeon, seeing dozens of patients a day and bringing in millions of dollars in fees for his suburban New York medical group. Over the past five months, thousands of patients have received notices from several insurance companies that Panos had posed as another doctor in order to review their medical records in coverage disputes. At least 2,500 people nationwide were affected, according to data compiled by Bloomberg, but the full reach of the alleged fraud hasn’t been made public.
UnitedHealth Group (UNH) closed the most recent trading day at $266.04, moving +0.53% from the previous trading session.
UnitedHealth Group Inc. bought pharmacy company Genoa Healthcare from private equity group Advent International. UnitedHealth, the biggest U.S. health insurer, beat out other parties including drugstore chain Walgreens Boots Alliance, which was said to be interested in Genoa in August, according to the person, who requested anonymity because the talks were private. Genoa runs more than 425 pharmacies in behavioral-health centers in 46 states, according to its website, serving more than 650,000 people.
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.